secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCULAR THERAPEUTIX, INC (OCUL)
CIK:        0001393434
Form:       8-K
Filed at:   2022-09-30T23:59:59+00:00
Accession:  0001104659-22-104258
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocular Therapeutix to disclose interim Phase 1 data for OTX-TKI at AAO 2022
---------------------------------------------------------------------------

- Company posted slides from Eyecelerator @ AAO 2022 Retina Showcase on its website.
- Interim data from U.S. Phase 1 trial of OTX-TKI to be presented at AAO Retina Subspecialty Day on Sept 30, 2022.
- Presentations by Dr. Peter Kaiser (Chief Medical Advisor, Retina) and Dr. Dilsher Dhoot.
- No specific results or data included in the 8-K filing; materials to be posted on investors section.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1393434/000110465922104258/0001104659-22-104258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1393434/000110465922104258/tm2227088d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-104258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer